BRYAN DWORSKY: Open Payments
NPI 1972957769 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 13 payments from 10 companies in 2025. Trend: 2023 $346 · 2024 $227 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| Dexcom, Inc. | 2 | $45 |
| Braeburn Inc. | 2 | $42 |
| Abbott Laboratories | 1 | $24 |
| Boston Scientific Corporation | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Indivior Inc. | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: CAPLYTA, Dexcom G6 Transmitter, BRIXADI, FREESTYLE LIBRE 3, WATCHMAN FLX, ELIQUIS, MOUNJARO, SHINGRIX.
Industry payments across NY — which companies pay providers there.
